Skip to main navigation Skip to search Skip to main content

Droplet Tn-Seq identifies the primary secretion mechanism for yersiniabactin in Yersinia pestis

  • Sarah L. Price
  • , Derek Thibault
  • , Taylor M. Garrison
  • , Amanda Brady
  • , Haixun Guo
  • , Thomas E. Kehl-Fie
  • , Sylvie Garneau-Tsodikova
  • , Robert D. Perry
  • , Tim van Opijnen
  • , Matthew B. Lawrenz

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Nutritional immunity includes sequestration of transition metals from invading pathogens. Yersinia pestis overcomes nutritional immunity by secreting yersiniabactin to acquire iron and zinc during infection. While the mechanisms for yersiniabactin synthesis and import are well-defined, those responsible for yersiniabactin secretion are unknown. Identification of this mechanism has been difficult because conventional mutagenesis approaches are unable to inhibit trans-complementation by secreted factors between mutants. To overcome this obstacle, we utilized a technique called droplet Tn-seq (dTn-seq), which uses microfluidics to isolate individual transposon mutants in oil droplets, eliminating trans-complementation between bacteria. Using this approach, we first demonstrated the applicability of dTn-seq to identify genes with secreted functions. We then applied dTn-seq to identify an AcrAB efflux system as required for growth in metal-limited conditions. Finally, we showed this efflux system is the primary yersiniabactin secretion mechanism and required for virulence during bubonic and pneumonic plague. Together, these studies have revealed the yersiniabactin secretion mechanism that has eluded researchers for over 30 years and identified a potential therapeutic target for bacteria that use yersiniabactin for metal acquisition.

Original languageEnglish
Article numbere57369
JournalEMBO Reports
Volume24
Issue number10
DOIs
StatePublished - Oct 9 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors.

Funding

The authors would like to acknowledge Dr. Joe Burlison at the Medicinal Chemistry Facility at the University of Louisville, Michelle Hallenbeck, and the University of Louisville's Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases Shared Resources and Vivarium Staff for their technical support during these studies. The authors would also like to thank Drs. Oleg V. Tsodikov, Juan Ortiz‐Marquez, and Noemi Bujan Gomez for critical feedback and discussions of data. Finally, the authors would like to thank Dr. Ralph Isberg for discussions and introductions that lead to this collaboration between the Lawrenz and van Opijnen labs. This work was supported by funding from the National Institutes of Health NIAID T32AI132146 (SLP), F31AI147404 (SLP), R01AI155611 (TEK), R01AI110724 (TvO), R01AI148470 (TvO), U01AI124302 (TvO), R21AI135225 (MBL), R01AI148241 (MBL), NIGMS P20GM125504 (MBL), and in part from the Jewish Heritage Foundation for Excellence Grant Program at the University of Louisville School of Medicine (MBL). The authors would like to acknowledge Dr. Joe Burlison at the Medicinal Chemistry Facility at the University of Louisville, Michelle Hallenbeck, and the University of Louisville's Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases Shared Resources and Vivarium Staff for their technical support during these studies. The authors would also like to thank Drs. Oleg V. Tsodikov, Juan Ortiz-Marquez, and Noemi Bujan Gomez for critical feedback and discussions of data. Finally, the authors would like to thank Dr. Ralph Isberg for discussions and introductions that lead to this collaboration between the Lawrenz and van Opijnen labs. This work was supported by funding from the National Institutes of Health NIAID T32AI132146 (SLP), F31AI147404 (SLP), R01AI155611 (TEK), R01AI110724 (TvO), R01AI148470 (TvO), U01AI124302 (TvO), R21AI135225 (MBL), R01AI148241 (MBL), NIGMS P20GM125504 (MBL), and in part from the Jewish Heritage Foundation for Excellence Grant Program at the University of Louisville School of Medicine (MBL).

FundersFunder number
Jewish Heritage Foundation
University of Louisville School of Medicine
National Institutes of Health (NIH)R01AI155611, F31AI147404, R01AI110724, T32AI132146
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical SciencesP20GM125504
Marine Biological Laboratory
University of Kentucky, University of Louisville
Teollisuuden Voima OyjR21AI135225, R01AI148241, R01AI148470, U01AI124302

    Keywords

    • Yersinia pestis
    • drug efflux systems
    • plague
    • siderophores
    • transposon mutagenesis

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Biology
    • Genetics

    Fingerprint

    Dive into the research topics of 'Droplet Tn-Seq identifies the primary secretion mechanism for yersiniabactin in Yersinia pestis'. Together they form a unique fingerprint.

    Cite this